Literature DB >> 24866390

Transparency in reimbursement decisions: in whose best interest?

Tania Stafinski1, Devidas Menon.   

Abstract

Mesh：

Year:  2014        PMID： 24866390     DOI： 10.1007/s40273-014-0176-4

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

2.  On bias and transparency in the development of influential recommendations.

Authors:  Andreas Laupacis
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

Review 3.  Health technology funding decision-making processes around the world: the same, yet different.

Authors:  Tania Stafinski; Devidas Menon; Donald J Philippon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 4.  Role of patient and public participation in health technology assessment and coverage decisions.

Authors:  Devidas Menon; Tania Stafinski
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-02       Impact factor: 2.217

5.  The ethics of accountability in managed care reform.

Authors:  N Daniels; J Sabin
Journal:  Health Aff (Millwood)       Date:  1998 Sep-Oct       Impact factor: 6.301
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.